Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

被引：0
|
作者：
B. Rossetti
C. Bianco
A. De Luca
机构：
[1] University of Siena,Second Division of Infectious Diseases, Policlinico Le Scotte
来源：
Infection | 2012年 / 40卷
关键词：
Human Immunodeficiency Virus; Sustained Virological Response; HBeAg Seroconversion; HBsAg Level; Biochemical Liver Function Test;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 349
页数：2
相关论文
共 50 条
  • [11] Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
    Li, Ming-Hui
    Zhang, Lu
    Qu, Xiao-Jing
    Lu, Yao
    Shen, Ge
    Wu, Shu-Ling
    Chang, Min
    Liu, Ru-Yu
    Hu, Lei-Ping
    Li, Zhen-Zhen
    Hua, Wen-Hao
    Song, Shu-Jing
    Xie, Yao
    CHINESE MEDICAL JOURNAL, 2017, 130 (05) : 559 - 565
  • [12] Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
    Li Ming-Hui
    Zhang Lu
    Qu Xiao-Jing
    Lu Yao
    Shen Ge
    Wu Shu-Ling
    Chang Min
    Liu Ru-Yu
    Hu Lei-Ping
    Li Zhen-Zhen
    Hua Wen-Hao
    Song Shu-Jing
    Xie Yao
    中华医学杂志英文版, 2017, 130 (05) : 559 - 565
  • [13] The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon
    Cooksley, G
    JOURNAL OF HEPATOLOGY, 2003, 39 : S143 - S145
  • [14] Transient Hepatitis B Surface Antigenemia After Hepatitis B Virus Vaccine in an HIV-Infected Patient
    Barbour, Sarah
    Bachmann, Laura
    Nunez, Marina
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (04) : 639 - 640
  • [15] Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
    Zhang, Wenhong
    Zhang, Dazhi
    Dou, Xiaoguang
    Xie, Qing
    Jiang, Jiaji
    Chen, Xinyue
    Ren, Hong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) : 1 - 10
  • [16] LOSS OF HBSAG AFTER INTERFERON-ALPHA TREATMENT - CURE OF CHRONIC HEPATITIS-B VIRUS
    DAVIS, GL
    HEPATOLOGY, 1991, 14 (05) : 953 - 954
  • [17] 48 Weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection
    Hui, CK
    Lai, LSW
    Lam, P
    Zhang, HY
    Fung, TT
    Lai, ST
    Wong, WM
    Lo, CM
    Fan, ST
    Leung, N
    Lau, GKK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1171 - 1178
  • [18] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [19] EFFECTS OF INTERFERON-ALPHA TREATMENT ON HEPATITIS-B VIRUS ANTIGEN-SPECIFIC IMMUNOLOGICAL RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS-B
    ISHIKAWA, T
    KAKUMU, S
    YOSHIOKA, K
    KUROKAWA, S
    KUSAKABE, A
    TAHARA, H
    HIROFUJI, H
    KAWABE, M
    LIVER, 1993, 13 (02): : 95 - 101
  • [20] Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    Callens, S
    Bottieau, E
    Michielsen, P
    Colebunders, R
    AIDS, 2004, 18 (01) : 131 - 131
12345